NASDAQ Biotechnology(NBI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NBI NASDAQ Biotechnology

Not Yet Opened 01-02 16:00:00 EST

5,706.69

-0.50

-0.01%

High5,730.56	Low5,657.70	Vol0.00
Open5,723.48	D1 Closing5,707.20	Amplitude1.28%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O--	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NBI","market":"US","secType":"STK","nameCN":"NASDAQ Biotechnology","latestPrice":5706.6943,"timestamp":1767387600000,"preClose":5707.1987,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-0.5044,"latestTime":"01-02 16:00:00 EST","open":5723.48,"high":5730.562,"low":5657.703,"amount":0,"amplitude":0.012766,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1767603600000},"marketStatusCode":0,"adr":0,"adjPreClose":5707.1987,"symbolType":"index"},"requestUrl":"/m/hq/s/NBI/wiki","defaultTab":"wiki","newsList":[{"id":"2593941230","title":"Upstream Bio (UPB): Reassessing Valuation After NASDAQ Biotechnology Index Inclusion and Sharp 3‑Month Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2593941230","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593941230?lang=en_us&edition=fundamental","pubTime":"2025-12-23 22:15","pubTimestamp":1766499309,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) just earned a spot in the NASDAQ Biotechnology Index, a visibility upgrade that can quietly reshape its investor base, trading volume, and how the market values its pipeline.\nSee our latest analysis for Upstream Bio.\nThat index inclusion lands on top of already strong momentum, with the share price at $30.43 and an 86.92% 3 month share price return that suggests investors are re-rating its risk and growth profile rather than just reacting to a one day move.\nIf this kind of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-upb/upstream-bio/news/upstream-bio-upb-reassessing-valuation-after-nasdaq-biotechn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-upb/upstream-bio/news/upstream-bio-upb-reassessing-valuation-after-nasdaq-biotechn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["USAW.SI","PSQ","NQmain","TSYW.SI","TQQQ",".IXIC","NVIW.SI","UPB","NBI","SQQQ","QID","MNQmain","QLD","USJW.SI","BK4139"],"gpt_icon":1},{"id":"2592096359","title":"Press Release: National Bank Investments Announces December 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2592096359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592096359?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:30","pubTimestamp":1766064600,"startTime":"0","endTime":"0","summary":"Unitholders of record on December 30, 2025, will receive cash distributions on January 7, 2026, as detailed in the table below.ETF or ETF Series name          Ticker symbol  Cash           Paymentfrequency. NBI Global Real Assets Income   NREA           $0.010396      Monthly. NBI High Yield Bond ETF         NHYB           $0.111633      Monthly. NBI Global Private Equity ETF   NGPE           $0.832270      Annual. NBI Active U.S. Equity ETF      NUSA           -              Quarterly. NBI Active U.S. Equity ETF -    NUSA.F         -              Quarterly. NBI Canadian Core Plus Bond     NCPB           -              Monthly. NBI Innovators Fund - ETF       NINV           -              Annual. NBI Innovators Fund - ETFH      NINV.F         -              Annual. NBI Quebec Growth Fund - ETF    NBQC           -              Annual. NBI U.S. Equity Fund - ETF      NBUE           -              Annual. NBI U.S. Equity Fund - ETFH     NBUE.F         -              Annual. NBI Global Equ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0310800965.SGD","BK4532","LU1244550221.USD","LU2237443549.SGD","US2Y.BOND","LU0211327993.USD","LU0211328371.USD","NBI","LU1267930227.SGD","US6M.BOND","LU2237443622.USD","FDN","BK4155","TLTW","BK4596","BK4588","US5Y.BOND","US7Y.BOND","BK4533","BK4550","BK4597","TGT","LU0823411888.USD","BK4504","US3Y.BOND","LU2237443978.SGD","LU1244550494.USD","LU1244550577.SGD","TMF","LU2237443382.USD","NBHC","US30Y.BOND","US10Y.BOND","LU1267930490.SGD","LU0310799852.SGD","BK4211","US12M.BOND","BK4114","LU0128525689.USD","LU0052756011.USD"],"gpt_icon":1},{"id":"2589876889","title":"Neurocrine Biosciences (NBIX) valuation update after NBI-1070770 Phase 2 trial failure reshapes pipeline expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2589876889","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589876889?lang=en_us&edition=fundamental","pubTime":"2025-12-07 14:11","pubTimestamp":1765087888,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) just shared a key clinical update, revealing that its investigational depression drug NBI-1070770 missed the primary efficacy endpoint in a Phase 2 trial, raising new questions about the company’s broader pipeline strategy.\nSee our latest analysis for Neurocrine Biosciences.\nDespite the setback, Neurocrine’s share price has held up reasonably well, with the stock at $155.51 and showing a 90 day share price return of 8.14 percent. Its 1 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-valuation-update-after-nbi-10707","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-valuation-update-after-nbi-10707","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NBI","BK4139","LU2065169927.USD","LU0109394709.USD","LU0154245756.USD","LU2065171311.SGD","LU0889565916.HKD","LU2065171402.SGD","LU0320765992.SGD","LU0154245673.USD","NBIX","LU0823416689.USD","LU2065170008.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2583050978","title":"Press Release: National Bank Investments Announces November 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2583050978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583050978?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:30","pubTimestamp":1763127000,"startTime":"0","endTime":"0","summary":"MONTREAL, Nov. 14, 2025 /CNW/ - National Bank Investments Inc.  announced today the November 2025 cash distribution amounts per unit for certain NBI Exchange-Traded Funds  and ETF Series of NBI Funds .Unitholders of record on November 21, 2025, will receive cash distributions on November 28, 2025, as detailed in the table below.NBI Global Real Assets Income ETF       NREA          $0.0500       Monthly. NBI Active Canadian Preferred Shares    NPRF          $0.1000       Monthly. NBI Unconstrained Fixed Income ETF      NUBF          $0.0800       Monthly. NBI Sustainable Canadian Bond ETF       NSCB          $0.0700       Monthly. NBI Sustainable Canadian Short Term     NSSB          $0.0260       Monthly. NBI Target 2026 Investment Grade Bond   NTGA          $0.0100       Monthly. NBI Target 2027 Investment Grade Bond   NTGB          $0.0130       Monthly. NBI Target 2029 Investment Grade Bond   NTGD          $0.0150       Monthly. National Bank Investments  Inc.  is an investment fund","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","FDN","LU1267930227.SGD","LU1267930490.SGD","TGT","US12M.BOND","LU0211327993.USD","LU2237443382.USD","LU0823411888.USD","US5Y.BOND","TMF","BK4597","US2Y.BOND","LU0128525689.USD","BK4550","BK4588","US6M.BOND","BK4585","BK4114","BK4533","LU0052756011.USD","TLTW","LU2237443549.SGD","US30Y.BOND","BK4532","BK4155","BK4596","LU2237443978.SGD","US10Y.BOND","LU0310800965.SGD","BK4211","LU2237443622.USD","LU1244550577.SGD","LU1244550221.USD","NBHC","US3Y.BOND","NBI","US7Y.BOND","LU0310799852.SGD","LU1244550494.USD","LU0211328371.USD"],"gpt_icon":1},{"id":"2582388338","title":"Neurocrine says Phase 2 study of NBI-1070770 did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2582388338","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582388338?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:16","pubTimestamp":1762809366,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-107...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-says-phase-2-study-of-nbi-1070770-did-not-meet-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-says-phase-2-study-of-nbi-1070770-did-not-meet-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2065171402.SGD","LU0109394709.USD","LU2065170008.USD","LU0154245673.USD","LU0823416689.USD","NBI","LU0889565916.HKD","LU2065171311.SGD","LU0154245756.USD","LU2065169927.USD","NBIX","BK4139","LU2324357040.USD"],"gpt_icon":0},{"id":"2579186605","title":"Neurocrine Biosciences Completes Phase 2 Study on NBI-1070770 for Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2579186605","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579186605?lang=en_us&edition=fundamental","pubTime":"2025-10-30 00:30","pubTimestamp":1761755429,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (($NBIX)) announced an update on their ongoing clinical study. Neurocrine Biosciences has recently completed a Phase 2 clini...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-completes-phase-2-study-on-nbi-1070770-for-depression?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-completes-phase-2-study-on-nbi-1070770-for-depression?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBI","BK4139","LU2065169927.USD","LU0109394709.USD","LU0154245756.USD","LU2065171311.SGD","LU0889565916.HKD","LU2065171402.SGD","LU0320765992.SGD","LU0154245673.USD","NBIX","LU0823416689.USD","LU2065170008.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2576203278","title":"Press Release: National Bank Investments Announces October 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2576203278","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576203278?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:00","pubTimestamp":1760702400,"startTime":"0","endTime":"0","summary":"MONTREAL, Oct. 17, 2025 /CNW/ - National Bank Investments Inc.  announced today the October 2025 cash distribution amounts per unit for certain NBI Exchange-Traded Funds  and ETF Series of NBI Funds .Unitholders of record on October 24, 2025, will receive cash distributions on October 31, 2025, as detailed in the table below.NBI Global Real Assets Income ETF             NREA    $0.0587       Monthly. NBI Active Canadian Preferred Shares ETF      NPRF    $0.1000       Monthly. NBI Unconstrained Fixed Income ETF            NUBF    $0.0850       Monthly. NBI High Yield Bond ETF                       NHYB    $0.1200       Monthly. NBI Sustainable Canadian Bond ETF             NSCB    $0.0800       Monthly. NBI Sustainable Canadian Corporate Bond ETF   NSCC    $0.0650       Monthly. NBI Sustainable Canadian Short Term Bond ETF  NSSB    $0.0300       Monthly. NBI Canadian Dividend Income ETF              NDIV    $0.0700       Monthly. NBI Target 2026 Investment Grade Bond Fund    NTGA    $0.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGT","BK4155","NBHC","BK4597","LU2237443622.USD","BK4533","BK4211","US7Y.BOND","BK4114","LU0128525689.USD","BK4532","LU1267930490.SGD","LU0211327993.USD","US30Y.BOND","US5Y.BOND","LU1244550577.SGD","US2Y.BOND","BK4585","LU2237443978.SGD","NBI","LU0310799852.SGD","LU0052756011.USD","BK4588","LU1244550494.USD","BK4504","BK4550","US3Y.BOND","BK4596","LU0310800965.SGD","LU0211328371.USD","LU1244550221.USD","US10Y.BOND","US12M.BOND","TLTW","LU1267930227.SGD","US6M.BOND","FDN","LU2237443549.SGD","LU0823411888.USD","LU2237443382.USD","TMF"],"gpt_icon":1},{"id":"1127932194","title":"NIRAKU (01245): NBI Plans to Acquire Land and Buildings in Atami, Shizuoka Prefecture for 791 Million JPY","url":"https://stock-news.laohu8.com/highlight/detail?id=1127932194","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127932194?lang=en_us&edition=fundamental","pubTime":"2025-10-16 18:52","pubTimestamp":1760611965,"startTime":"0","endTime":"0","summary":"NIRAKU (01245) announced that on October 16, 2025 (after trading hours), NBI, a wholly-owned subsidiary of the company, entered into a sales agreement with Keeth Partners, an independent third-party...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBI","BK1172","01245"],"gpt_icon":0},{"id":"2567119244","title":"Press Release: National Bank Investments Announces September 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2567119244","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567119244?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:00","pubTimestamp":1757937600,"startTime":"0","endTime":"0","summary":"MONTREAL, Sept. 15, 2025 /CNW/ - National Bank Investments Inc.  announced today the September 2025 cash distribution amounts per unit for certain NBI Exchange-Traded Funds  and ETF Series of NBI Funds .Unitholders of record on September 22, 2025, will receive cash distributions on September 29, 2025, as detailed in the table below.ETF Name                  Ticker Symbol  Cash Distributionper Unit  Payment. NBI High Yield Bond ETF   NHYB           $0.1050                    Monthly. NBI ETFs and NBI ETF Series are offered by National Bank Investments Inc., an indirect wholly owned subsidiary of National Bank of Canada and sold by authorized dealers. Management fees, brokerage fees and expenses all may be associated with investments in NBI ETFs or NBI ETF Series. Please read the simplified prospectus or ETF Facts documents before investing. NBI ETFs and ETF Series of NBI Funds are not guaranteed, their values change frequently, and past performance may not be repeated. NBI ETF units and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US12M.BOND","BK4550","BK4585","FDN","NBI","US10Y.BOND","US30Y.BOND","US7Y.BOND","NBHC","BK4211","US6M.BOND","BK4588","US3Y.BOND","US2Y.BOND","US5Y.BOND"],"gpt_icon":0},{"id":"2559911373","title":"Press Release: National Bank Investments Announces August 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2559911373","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559911373?lang=en_us&edition=fundamental","pubTime":"2025-08-15 20:00","pubTimestamp":1755259200,"startTime":"0","endTime":"0","summary":"MONTREAL, Aug. 15, 2025 /CNW/ - National Bank Investments Inc.  announced today the August 2025 cash distribution amounts per unit for certain NBI Exchange-Traded Funds  and ETF Series of NBI Funds .Unitholders of record on August 22, 2025, will receive cash distributions on August 29, 2025, as detailed in the table below.NBI Global Real Assets Income ETF     NREA    $0.0600               Monthly. NBI Active Canadian Preferred Shares  NPRF    $0.1000               Monthly. NBI Unconstrained Fixed Income ETF    NUBF    $0.0850               Monthly. Guided by an open architecture strategy, NBI is dedicated to providing diverse solutions to meet the evolving needs of its clients. NBI consistently strives to be recognized as a key partner by combining innovation and excellence. NBI's role is not limited to administrative aspects of management; NBI Advisory Services and its registered representatives form a team of specialists who provide information and advice to help advisors build port","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US5Y.BOND","BK4211","US6M.BOND","US30Y.BOND","US12M.BOND","FDN","US7Y.BOND","US3Y.BOND","US10Y.BOND","NBI","NBHC","US2Y.BOND","BK4585","BK4588","BK4550"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":-0.0011},{"period":"3month","weight":0.0209},{"period":"6month","weight":0.0925},{"period":"1year","weight":0.1685},{"period":"ytd","weight":0.0018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022186},{"month":2,"riseRate":0.5,"avgChangeRate":0.003877},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.01598},{"month":4,"riseRate":0.53125,"avgChangeRate":0.001966},{"month":5,"riseRate":0.5625,"avgChangeRate":0.015518},{"month":6,"riseRate":0.5625,"avgChangeRate":0.014583},{"month":7,"riseRate":0.65625,"avgChangeRate":0.027584},{"month":8,"riseRate":0.59375,"avgChangeRate":0.01258},{"month":9,"riseRate":0.4375,"avgChangeRate":0.005593},{"month":10,"riseRate":0.40625,"avgChangeRate":-0.002731},{"month":11,"riseRate":0.71875,"avgChangeRate":0.03022},{"month":12,"riseRate":0.575758,"avgChangeRate":0.023416}],"exchange":"NASDAQ","name":"NASDAQ Biotechnology","nameEN":"NASDAQ Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NASDAQ Biotechnology(NBI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest NASDAQ Biotechnology(NBI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"NASDAQ Biotechnology,NBI,NASDAQ Biotechnology股票,NASDAQ Biotechnology股票老虎,NASDAQ Biotechnology股票老虎国际,NASDAQ Biotechnology行情,NASDAQ Biotechnology股票行情,NASDAQ Biotechnology股价,NASDAQ Biotechnology股市,NASDAQ Biotechnology股票价格,NASDAQ Biotechnology股票交易,NASDAQ Biotechnology股票购买,NASDAQ Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NASDAQ Biotechnology(NBI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest NASDAQ Biotechnology(NBI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction